Established CEOLIA Pharma Co.,Ltd., as a joint venture of ASKA Pharmaceutical Co., Ltd. and Senju Pharmaceutical Co., Ltd.
(Capital of 30 million yen, 2-5-1 Shibaura, Minato-ku, Tokyo)
Started promotional business of ENT-related medical drugs.
Head Office shifted to 3-3-1 Nihonbashi Muromachi Chuo-ku Tokyo
CEOLIA obtains permission of First-class and Second-class Marketing Authorization Holders
Opened Osaka sales offices in 1-8-29 Nishimiyahara Yodogawa-ku, Osaka-shi.
Opened Fukuoka sales office in 9-12 Shimokawabata-cho Hakata-ku, Fukuoka-shi.
Opened a Tokyo office in 1-1-32 Nihonbashi,Ningyo-cho Chuo-ku, Tokyo
Closure of Tokyo Office and establishment of new office in 4-3-16 Nihonbashimuromachi Chuo-ku, Tokyo
Opened a logistics warehouse in 47-1 Kiyohisa-cho Kuki-shi Saitama Prefecture .
Signed one hand sales contract with Takeda Pharmaceutical Company Limited and
(Start of the direct transactions with Takeda Pharmaceutical Company Limited)
Transfer of Kansai Sales Office to 3-1-9 Awaji-cho Chuo-ku, Osaka-shi.